Evotec launches new cGMP biologics facility
Manufacturing center expected to integrate data analytics, machine learning into production process
Evotec SE has opened its company’s late-stage clinical and commercial biologics current good manufacturing practice (cGMP) manufacturing facility in Redmond, WA. The 130,000 square-foot biomanufacturing center is the final step in Just – Evotec Biologics’ J.DESIGN platform that incorporates data analytics and machine learning through all activities involved with biologics discovery, development and manufacturing. This includes design of discovery libraries, molecules, processes and the manufacturing facility itself, J.POD.
The site is powered by technology that uses autonomous clean rooms to run small, highly intensified production processes, which are expected to decrease the cost of biologics manufacturing. Personnel will also find dedicated quality control and process development laboratories for both clinical and commercial products, a warehouse, and collaborative office and meeting spaces for approximately 200 employees at full capacity.
According to Evotec, the facility was designed with improved environmental sustainability and was built in 19 months (after breaking ground in late 2019), compared to an industry standard of up to 4-plus years for a traditional biologics manufacturing site.
